Fédor Svinartchouk

695 total citations
17 papers, 537 citations indexed

About

Fédor Svinartchouk is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fédor Svinartchouk has authored 17 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fédor Svinartchouk's work include Muscle Physiology and Disorders (6 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Fédor Svinartchouk is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Fédor Svinartchouk collaborates with scholars based in France, United States and United Kingdom. Fédor Svinartchouk's co-authors include Luis Garcı́a, Thibaut Léger, Jean‐Michel Camadro, Camille Garcia, Dominique Dumènil, William Vainchenker, Catherine Lacout, Laurent Servais, Bjarne Udd and Brenda Wong and has published in prestigious journals such as Nucleic Acids Research, Blood and Journal of Virology.

In The Last Decade

Fédor Svinartchouk

17 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fédor Svinartchouk France 13 396 173 96 81 58 17 537
Bijoy Thattaliyath United States 9 446 1.1× 277 1.6× 233 2.4× 77 1.0× 73 1.3× 23 667
Stuart Ellison United Kingdom 14 250 0.6× 109 0.6× 34 0.4× 74 0.9× 116 2.0× 27 552
Stamatis Papathanasiou United States 6 551 1.4× 144 0.8× 79 0.8× 111 1.4× 10 0.2× 6 666
Stephanie Salabarria United States 3 371 0.9× 278 1.6× 56 0.6× 22 0.3× 13 0.2× 5 537
Ephrem Chin United States 10 256 0.6× 155 0.9× 29 0.3× 19 0.2× 18 0.3× 16 431
Juliane Menezes Portugal 13 294 0.7× 82 0.5× 37 0.4× 20 0.2× 99 1.7× 23 572
Ella G. Frolova United States 7 462 1.2× 60 0.3× 66 0.7× 38 0.5× 11 0.2× 9 640
Bernard Gjata France 15 375 0.9× 330 1.9× 36 0.4× 24 0.3× 17 0.3× 26 694
Charlotte Brandt Sørensen Denmark 13 385 1.0× 205 1.2× 41 0.4× 65 0.8× 8 0.1× 32 572
van Ommen Gj Netherlands 4 327 0.8× 134 0.8× 42 0.4× 20 0.2× 41 0.7× 5 445

Countries citing papers authored by Fédor Svinartchouk

Since Specialization
Citations

This map shows the geographic impact of Fédor Svinartchouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fédor Svinartchouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fédor Svinartchouk more than expected).

Fields of papers citing papers by Fédor Svinartchouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fédor Svinartchouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fédor Svinartchouk. The network helps show where Fédor Svinartchouk may publish in the future.

Co-authorship network of co-authors of Fédor Svinartchouk

This figure shows the co-authorship network connecting the top 25 collaborators of Fédor Svinartchouk. A scholar is included among the top collaborators of Fédor Svinartchouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fédor Svinartchouk. Fédor Svinartchouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Relizani, Karima, Lucía Echevarría, Thibaut Larcher, et al.. (2021). Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides. Nucleic Acids Research. 50(1). 17–34. 30 indexed citations
2.
Echevarría, Lucía, Karima Relizani, Graziella Griffith, et al.. (2019). Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model. Nucleic Acid Therapeutics. 29(3). 148–160. 21 indexed citations
3.
Echevarría, Lucía, Karima Relizani, Grégory Jouvion, et al.. (2019). Identifying and Avoiding tcDNA-ASO Sequence-Specific Toxicity for the Development of DMD Exon 51 Skipping Therapy. Molecular Therapy — Nucleic Acids. 19. 371–383. 20 indexed citations
4.
Lefèbvre, Thibaud, Raêd Daher, Jérôme Ausseil, et al.. (2018). High urinary ferritin reflects myoglobin iron evacuation in DMD patients. Neuromuscular Disorders. 28(7). 564–571. 10 indexed citations
5.
Léger, Thibaut, Camille Garcia, Graziella Griffith, et al.. (2018). AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6. Molecular Therapy — Methods & Clinical Development. 10. 291–302. 36 indexed citations
6.
Gicquel, Evelyne, William Martin, Nathalie Bourg, et al.. (2017). AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression. Human Molecular Genetics. 26(10). 1952–1965. 35 indexed citations
7.
Poupiot, Jérôme, Aleksandar Zocevic, Fatima Amor, et al.. (2015). Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Human Molecular Genetics. 24(17). 4916–4932. 50 indexed citations
8.
Zocevic, Aleksandar, Thibaut Léger, Camille Garcia, et al.. (2014). Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy. Neuromuscular Disorders. 24(7). 563–573. 81 indexed citations
9.
Blouin, Véronique, et al.. (2014). Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates. Molecular Therapy — Methods & Clinical Development. 1. 14031–14031. 5 indexed citations
10.
Marolleau, Béatrice, et al.. (2013). C-Reactive Protein (CRP) Is Essential for Efficient Systemic Transduction of Recombinant Adeno-Associated Virus Vector 1 (rAAV-1) and rAAV-6 in Mice. Journal of Virology. 87(19). 10784–10791. 29 indexed citations
11.
Beley, Cyriaque, Robert M. Kotin, René Lai–Kuen, et al.. (2012). Human Galectin 3 Binding Protein Interacts with Recombinant Adeno-Associated Virus Type 6. Journal of Virology. 86(12). 6620–6631. 54 indexed citations
12.
Bouazza, Belaïd, Gueorgui Kratassiouk, Bernard Gjata, et al.. (2009). Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: A pilot study. Neuromuscular Disorders. 19(3). 199–206. 3 indexed citations
13.
Laroudie, Nicolas, Florence Gonnet, Luigi Naldini, et al.. (2009). Quantitative proteomic analysis of lentiviral vectors using 2‐DE. PROTEOMICS. 9(14). 3666–3676. 26 indexed citations
14.
Gonnet, Florence, Belaïd Bouazza, Gaël A. Millot, et al.. (2008). Proteome analysis of differentiating human myoblasts by dialysis‐assisted two‐dimensional gel electrophoresis (DAGE). PROTEOMICS. 8(2). 264–278. 21 indexed citations
15.
Danos, Olivier & Fédor Svinartchouk. (2006). Dialysis‐assisted two‐dimensional gel electrophoresis. Electrophoresis. 27(17). 3475–3479. 2 indexed citations
16.
Capron, Claude, Yann Lécluse, Adlen Foudi, et al.. (2006). The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood. 107(12). 4678–4686. 61 indexed citations
17.
Garçon, Loïc, Catherine Lacout, Fédor Svinartchouk, et al.. (2004). Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood. 105(4). 1448–1455. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bijoy Thattaliyath Breakdown of academic impact, for papers by Stuart Ellison Breakdown of academic impact, for papers by Stamatis Papathanasiou Breakdown of academic impact, for papers by Stephanie Salabarria Breakdown of academic impact, for papers by Ephrem Chin Breakdown of academic impact, for papers by Juliane Menezes Breakdown of academic impact, for papers by Ella G. Frolova Breakdown of academic impact, for papers by Bernard Gjata Breakdown of academic impact, for papers by Charlotte Brandt Sørensen Breakdown of academic impact, for papers by van Ommen Gj
Rankless by CCL
2026